Issuance of shares

Severn Trent

01/10/2026 11:52

RNS Number : 2395X
  
Severn Trent PLC
  
01 October 2026
  
 


Severn Trent Plc ("Severn Trent" or "the Company")
Issuance of shares
 
In accordance with PRM 1.6.4R, the Company announces that between 1 September 2026 and 30 September 2026 it has allotted and issued 13,269 ordinary shares of 97 17/19 pence each for the purposes of satisfying the allotment of shares under the Severn Trent Sharesave Scheme. These shares have been admitted to trading on the London Stock Exchange Main Market under the Company's existing block admission of shares for this purpose dated 28 November 2025.
Following this issuance of shares, and in line with the 'Total Voting Rights and Issued Share Capital' announcement released by the Company on 1 October 2026, as at 30 September 2026 the Company's total issued share capital consisted of 304,076,354 ordinary shares of 97 17⁄19 pence each, of which 2,002,453 shares are held in treasury.
 




(1)     


Name and LEI of issuer


Severn Trent Plc
LEI: 213800RPBXRETY4A4C59




(2)     


Regulated market


London Stock Exchange Main Market




(3)     


Name, type and identification code


Ordinary shares of 97 17/19 pence each
ISIN: GB00B1FH8J72




(4)     


Number of further shares issued and admitted to trading


13,269




(5)     


Total number of shares admitted to trading following issuance


304,076,354




(6)     


Fungibility


Fully fungible with existing ordinary shares




 
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
IOEBFLFBQBLZFBK